Abeona Therapeutics Inc (NASDAQ: ABEO) — Healthcare · Share Price, Chart & Market Data
About: Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.39 (-2.36%)
ABEOAbeona Therapeutics Inc
Loading watchlist status…
Trade ABEO now
Abeona Therapeutics Inc share price
ABEO price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
26 Apr, 3:29 pm GMT+0
ABEO price performance
-1.642%
5D
24.48%
1M
1.507%
YTD
0%
1Y
ABEO price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
26 Apr, 3:29 pm GMT+0
ABEO details
ABEO Market Signals